申请人:Ferro Therapeutics, Inc.
公开号:US20190263802A1
公开(公告)日:2019-08-29
This present disclosure relates to compounds with ferroptosis inducing activity, a method of treating a subject with cancer with the compounds, and combination treatments with a second therapeutic agent.
本公开涉及具有诱导铁死亡活性的化合物,一种使用这些化合物治疗癌症患者的方法,以及与第二种治疗药物的联合治疗。